HBO2 THERAPEUTICS
HbO2 Therapeutics develops and manufactures oxygen-carrying solutions, a class of drug products that when administered intravenously can increase the amount of oxygen transported throughout the body. It offers two products. Hemopure [hemoglobin glutamer – 250 (bovine)], for use in humans, and Oxyglobin [hemoglobin glutamer – 200 (bovine)]) for veterinary use. The company was founded in 2014 and is headquartered in Souderton, Pennsylvania.
HBO2 THERAPEUTICS
Social Links:
Industry:
Biotechnology Developer Platform Health Care Manufacturing Therapeutics
Founded:
2014-01-01
Address:
Souderton, Pennsylvania, United States
Country:
United States
Website Url:
http://www.hbo2therapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(267) 382-0064
Email Addresses:
[email protected]
Total Funding:
2.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Apache Sitelinks Search Box Google Apps For Business PHP
Similar Organizations
CardioPhotonics
CardioPhotonics develops and markets non-invasive blood monitors to detect cardiac arrhythmia and dehydration.
Current Employees Featured
Founder
Official Site Inspections
http://www.hbo2therapeutics.com Semrush global rank: 4.39 M Semrush visits lastest month: 2.55 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "HbO2 Therapeutics"
About Us - HbO2 Therapeutics
Dr. Dubé has over 30 years of industry experience in drug R&D including leadership positions in large and small Pharma and biotech. Dr. Dubé is an expert in the physical, biochemical and …See details»
HbO2 Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number (267) 382-0064 HbO2 Therapeutics develops and manufactures oxygen-carrying solutions, a class of drug products that when administered intravenously can increase the amount …See details»
HbO2 Therapeutics - LinkedIn
Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics) is a leading developer and manufacturer of oxygen carrying solutions, a class of drug products that when administered intravenously can ...See details»
HbO2 Therapeutics - Org Chart, Teams, Culture & Jobs
View HbO2 Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
HbO2 Therapeutics - PitchBook
HbO2 Therapeutics General Information Description. Developer of human and veterinary hemoglobin-based oxygen carriers designed to help stabilize the patient and prevent tissue damage or organ dysfunction associated with …See details»
HbO2 Therapeutics - Company Profile - Tracxn
Oct 25, 2024 HbO2 Therapeutics - Developer of Hemoglobin-based solutions that increase oxygen-carrying capacity of blood. Raised a total funding of $1.45M over 2 rounds. Founded …See details»
Contact - HbO2 Therapeutics
Your message has been sent. Send. bottom of pageSee details»
Hemoglobin Oxygen Therapeutics - Overview, News & Similar
Hemoglobin Oxygen Therapeutics contact info: Phone number: (267) 382-0064 Website: www.hbo2therapeutics.com What does Hemoglobin Oxygen Therapeutics do? HbO 2 …See details»
HbO2 Therapeutics - Craft
HbO2 Therapeutics has 5 employees across 2 locations and $1.45 m in total funding,. See insights on HbO2 Therapeutics including office locations, competitors, revenue, financials, …See details»
Hemoglobin Oxygen Therapeutics LLC Announces the World's …
Oct 18, 2017 For more information please visit www.hbo2therapeutics.com. Contact: HbO 2 Therapeutics LLC Jerry Kowalski, CEO [email protected] Tel: +1 617 800 7215. SOURCE …See details»
Zaf Zafirelis - President and co-founder @ HbO2 Therapeutics ...
Primary Organization . HbO2 Therapeutics . Gender Male; Mr. Zafirelis has more than 25 years of CEO experience in private and public companies, including start-up ventures and turnaround …See details»
Hemoglobin Oxygen Therapeutics LLC Announces Preclinical …
Apr 9, 2019 For more information, please visit www.hbo2therapeutics.com. Contact Details Sunny Uberoi Chief Communications Officer 917.747.2018 [email protected] SOURCE …See details»
HbO2 Therapeutics - VentureRadar
Similar Companies: Bionor Labs Norway n/a Bionor Labs develops products for human and veterinary medicine including aqua culture.. Aniluxx Biotechnology USA Privately Held Aniluxx …See details»
Hemopure® to be evaluated in groundbreaking clinical study of …
Nov 8, 2018 For more information, please visit www.hbo2therapeutics.com. Contact: HbO 2 Therapeutics LLC Zaf Zafirelis, CEO +1 781-373-1835. SOURCE Hemoglobin Oxygen …See details»
Collaborations - HbO2 Therapeutics
We collaborate with institutions and key opinion leaders around the world. They include but are not limited to specialists in transfusion medicine, cardiology, trauma surgery, …See details»
Hemoglobin Oxygen Therapeutics LLC Announce Updated Results …
Feb 13, 2019 For more information, please visit www.hbo2therapeutics.com. Contact Details. Sunny Uberoi 917.747.2018 [email protected] SOURCE Hemoglobin Oxygen Therapeutics. …See details»
Media - HbO2 Therapeutics
The National Institute For Health And Care Excellence Approves Organ Perfusion For Use On The NHSSee details»
Hemopure - HbO2 Therapeutics
Hemopure is a hemoglobin-based oxygen carrier (HBOC) ready for immediate infusion, that transports and delivers oxygen from the plasma and expands the circulating volume.See details»
Other Media - HbO2 Therapeutics
Promising developments in research being conducted to restore previously discarded donor organsSee details»